Erratum: Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer’s Disease (PLoS Genetics (2016) 12:10 (e1006327) DOI: 10.1371/journal.pgen.1006327);Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease

PLoS Genetics

Volumn 12, Issue 10, 2016, Pages

  Jakobsdottir, Johanna ^a   van der Lee, Sven J ^b   Bis, Joshua C ^c   Chouraki, Vincent ^d,e   Li Kroeger, David ^f,g   Yamamoto, Shinya ^f,g   Grove, Megan L ^h   Naj, Adam ⁱ   Vronskaya, Maria ^j   Salazar, Jose L ^f   DeStefano, Anita L ^e,k   Brody, Jennifer A ^c   Smith, Albert V ^a,l   Amin, Najaf ^b   Sims, Rebecca ^j   Ibrahim Verbaas, Carla A ^b   Choi, Seung Hoan ^e,k   Satizabal, Claudia L ^d,e   Lopez, Oscar L ^m   Beiser, Alexa ^d,e,k   Ikram, M Arfan ^b   Garcia, Melissa E ⁿ   Hayward, Caroline ^o   Varga, Tibor V ^p   Ripatti, Samuli ^q   Franks, Paul W ^p,r,s   Hallmans, Göran ^t   Rolandsson, Olov ^t   Jansson, Jan Håkon ^r,u   Porteous, David J ^o   Salomaa, Veikko ^v   Eiriksdottir, Gudny ^a   Rice, Kenneth M ^w   Bellen, Hugo J ^f,g,x   Levy, Daniel ^d,e,y   Uitterlinden, Andre G ^b   Emilsson, Valur ^a,z   Rotter, Jerome I ^aa   Aspelund, Thor ^a,z   O’Donnell, Christopher J ^e,y   Fitzpatrick, Annette L ^w,ab   Launer, Lenore J ⁿ   Hofman, Albert ^b   Wang, Li San ⁱ   Williams, Julie ^j   Schellenberg, Gerard D ⁱ   Boerwinkle, Eric ^f,h   Psaty, Bruce M ^c,w,ac   Seshadri, Sudha ^d,e   Shulman, Joshua M ^f,g   Gudnason, Vilmundur ^a,l   van Duijn, Cornelia M ^b   more..

^a ICELANDIC HEART ASSOCIATION   (Iceland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e FRAMINGHAM HEART STUDY   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g TEXAS CHILDREN S HOSPITAL   (United States)

^h UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j Cardiff University   (United Kingdom)

^k BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF ICELAND   (Iceland)

^m UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

ⁿ NATIONAL INSTITUTE ON AGING   (United States)

^o UNIVERSITY OF EDINBURGH   (United Kingdom)

^p LUND UNIVERSITY   (Sweden)

^q UNIVERSITY OF HELSINKI   (Finland)

^r UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^s HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^t UMEÅ UNIVERSITY   (Sweden)

^u Skelleftea Hospital   (Sweden)

^v NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^w UNIVERSITY OF WASHINGTON   (United States)

^x HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^y NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^z UNIVERSITY OF ICELAND   (Iceland)

^aa HARBOR UCLA MEDICAL CENTER   (United States)

^ab Departments of Neurology and Epidemiology   (United States)

^ac CENTER FOR HEALTH STUDIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; MEMBRANE PROTEIN; NOTCH RECEPTOR; PRESENILIN; PROTEIN SKAP2; PROTEIN TM2D3; UNCLASSIFIED DRUG; AMX PROTEIN, DROSOPHILA; AMYLOID PRECURSOR PROTEIN; APOE PROTEIN, HUMAN; DROSOPHILA PROTEIN; SIGNAL PEPTIDE; SRC KINASE ASSOCIATED PHOSPHOPROTEIN 2; TM2D1 PROTEIN, HUMAN; TROPOMYOSIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 15Q; CONTROLLED STUDY; ETHNIC DIFFERENCE; EXOME; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; ICELANDER; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NONHUMAN; POPULATION BASED CASE CONTROL STUDY; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TM2D3 GENE; ALLELE; ANIMAL; CAUCASIAN; DROSOPHILA MELANOGASTER; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; ICELAND; MUTATION; ONSET AGE; PATHOLOGY; PHENOTYPE;

AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXOME; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; ICELAND; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; RECEPTORS, NOTCH; TROPOMYOSIN;

EID: 84994310331     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/JOURNAL.PGEN.1006456     Document Type: Erratum

References (59)

1. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16: 203–12. Available: http://www.ncbi.nlm.nih.gov/pubmed/12468894doi: 10.1097/00002093-200210000-0000112468894
2. Hebert LE, Weuve J, Scherr PA, Evans DA, Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 2013;80: 1778–83. doi: 10.1212/WNL.0b013e31828726f523390181
3. 2015 Alzheimer’s disease facts and figures. Alzheimers Dement. 2015;11: 332–84. Available: http://www.ncbi.nlm.nih.gov/pubmed/25984581doi: 10.1016/j.jalz.2015.02.00325984581
4. James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, Bennett DA, Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014;82: 1045–50. doi: 10.1212/WNL.000000000000024024598707
5. Cruts M, Theuns J, Van Broeckhoven C, Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat. 2012;33: 1340–4. doi: 10.1002/humu.2211722581678
6. Bekris LM, Yu C-E, Bird TD, Tsuang DW, Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23: 213–27. doi: 10.1177/089198871038357121045163
7. Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet. 2011;43: 436–41. doi: 10.1038/ng.80121460841
8. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet. 2011;43: 429–35. doi: 10.1038/ng.80321460840
9. Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009;41: 1094–9. doi: 10.1038/ng.43919734903
10. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41: 1088–93. doi: 10.1038/ng.44019734902
11. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303: 1832–40. doi: 10.1001/jama.2010.57420460622
12. Lambert J-C, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2013;45: 1452–8. doi: 10.1038/ng.280224162737
13. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43: 1467–1467. doi: 10.1212/WNL.43.8.14678350998
14. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90: 1977–81. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=46003&tool=pmcentrez&rendertype=abstractdoi: 10.1073/pnas.90.5.19778446617
15. Chouraki V, Seshadri S, Genetics of Alzheimer’s disease. Adv Genet. 2014;87: 245–94. doi: 10.1016/B978-0-12-800149-3.00005–625311924
16. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson P V, Bjornsson S, et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature. 2012;488: 96–9. doi: 10.1038/nature1128322801501
17. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson P V, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med. 2013;368: 107–16. doi: 10.1056/NEJMoa121110323150908
18. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer’s disease. N Engl J Med. 2013;368: 117–27. doi: 10.1056/NEJMoa121185123150934
19. Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease. Nature. 2014;505: 550–4. doi: 10.1038/nature1282524336208
20. Wetzel-Smith MK, Hunkapiller J, Bhangale TR, Srinivasan K, Maloney JA, Atwal JK, et al. A rare mutation in UNC5C predisposes to late-onset Alzheimer’s disease and increases neuronal cell death. Nat Med. 2014;20: 1452–7. doi: 10.1038/nm.373625419706
21. Logue MW, Schu M, Vardarajan BN, Farrell J, Bennett DA, Buxbaum JD, et al. Two rare AKAP9 variants are associated with Alzheimer’s disease in African Americans. Alzheimers Dement. 2014;10: 609–618.e11. doi: 10.1016/j.jalz.2014.06.01025172201
22. Zhang B, Gaiteri C, Bodea L-G, Wang Z, McElwee J, Podtelezhnikov AA, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell. Elsevier; 2013;153: 707–20. doi: 10.1016/j.cell.2013.03.03023622250
23. Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, et al. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener. 2014;9: 20. doi: 10.1186/1750-1326-9-2024893973
24. van der Lee SJ, Holstege H, Wong TH, Jakobsdottir J, Bis JC, Chouraki V, et al. PLD3 variants in population studies. Nature. 2015;520: E2–3. doi: 10.1038/nature1403825832410
25. Kiezun A, Garimella K, Do R, Stitziel NO, Neale BM, McLaren PJ, et al. Exome sequencing and the genetic basis of complex traits. Nat Genet. 2012;44: 623–30. doi: 10.1038/ng.230322641211
26. Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2: 73–80. doi: 10.1161/CIRCGENETICS.108.82974720031568
27. Radhakrishna Rao C, Bartlett MS, Large sample tests of statistical hypotheses concerning several parameters with applications to problems of estimation. Math Proc Cambridge Philos Soc. Cambridge University Press; 2008;44: 50. doi: 10.1017/S0305004100023987
28. Lumley T, Brody J, Dupuis J, Cupples A. Meta-analysis of a rare-variant association test. [Internet]. 2012. Available: http://stattech.wordpress.fos.auckland.ac.nz/files/2012/11/skat-meta-paper.pdf
29. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X, Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet. 2011;89: 82–93. doi: 10.1016/j.ajhg.2011.05.02921737059
30. Grove ML, Yu B, Cochran BJ, Haritunians T, Bis JC, Taylor KD, et al. Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One. 2013;8: e68095. doi: 10.1371/journal.pone.006809523874508
31. Kajkowski EM, Lo CF, Ning X, Walker S, Sofia HJ, Wang W, et al. beta -Amyloid peptide-induced apoptosis regulated by a novel protein containing a g protein activation module. J Biol Chem. 2001;276: 18748–56. doi: 10.1074/jbc.M01116120011278849
32. Michellod M-A, Randsholt NB, Implication of the Drosophila beta-amyloid peptide binding-like protein AMX in Notch signaling during early neurogenesis. Brain Res Bull. 2008;75: 305–9. doi: 10.1016/j.brainresbull.2007.10.06018331889
33. Stephens M, Scheet P, Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 2005;76: 449–62. doi: 10.1086/42859415700229
34. Stephens M, Donnelly P, A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73: 1162–9. doi: 10.1086/37937814574645
35. Stephens M, Smith NJ, Donnelly P, A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68: 978–89. doi: 10.1086/31950111254454
36. Yates A, Akanni W, Amode MR, Barrell D, Billis K, Carvalho-Silva D, et al. Ensembl 2016. Nucleic Acids Res. Oxford University Press; 2016;44: D710–D716. doi: 10.1093/nar/gkv115726687719
37. Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The Genotype-Tissue Expression (GTEx) project. Nat Genet. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2013;45: 580–5. doi: 10.1038/ng.265323715323
38. Vivian J, Rao A, Nothaft FA, Ketchum C, Armstrong J, Novak A, et al. Rapid and efficient analysis of 20,000 RNA-seq samples with Toil [Internet]. bioRxiv. Cold Spring Harbor Labs Journals; 2016 Jul. doi: 10.1101/062497
39. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7: 248–9. doi: 10.1038/nmeth0410-24820354512
40. Kumar P, Henikoff S, Ng PC, Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4: 1073–81. doi: 10.1038/nprot.2009.8619561590
41. Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J, A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46: 310–5. doi: 10.1038/ng.289224487276
42. Barnes MB, Gray IC. Bioinformatics for Geneticists [Internet]. 2003 [cited 11 May 2016]. Available: http://www.amazon.com/exec/obidos/tg/detail/-/0470843934/qid=1049297099/sr=8-7/ref=sr_8_7/103-1037454-5494226?v=glance&s=books&n=507846
43. Shannon MP, Characterization of the female-sterile mutant Almondex of Drosophila melanogaster. Genetica. 1972;43: 244–256. doi: 10.1007/BF001236324625164
44. Lehmann R, Dietrich U, Jimènez F, Campos-Ortega JA, Mutations of early neurogenesis inDrosophila. Wilhelm Roux’s Arch Dev Biol. 1981;190: 226–229. doi: 10.1007/BF00848307
45. Poulson DF, Chromosomal Deficiencies and the Embryonic Development of Drosophila Melanogaster. Proc Natl Acad Sci U S A. 1937;23: 133–7. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1076884&tool=pmcentrez&rendertype=abstractdoi: 10.1073/pnas.23.3.13316588136
46. Struhl G, Greenwald I, Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature. 1999;398: 522–5. doi: 10.1038/1909110206646
47. Goriely A, Dumont N, Dambly-Chaudière C, Ghysen A, The determination of sense organs in Drosophila: effect of the neurogenic mutations in the embryo. Development. 1991;113: 1395–404. Available: http://www.ncbi.nlm.nih.gov/pubmed/18119511811951
48. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009;10: R130. doi: 10.1186/gb-2009-10-11-r13019919682
49. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004;101: 6062–7. doi: 10.1073/pnas.040078210115075390
50. Zhang L, Guo XQ, Chu JF, Zhang X, Yan ZR, Li YZ, Potential hippocampal genes and pathways involved in Alzheimer’s disease: a bioinformatic analysis. Genet Mol Res. 2015;14: 7218–32. doi: 10.4238/2015.June.29.1526125932
51. Michellod M-A, Forquignon F, Santamaria P, Randsholt NB, Differential requirements for the neurogenic gene almondex during Drosophila melanogaster development. Genesis. 2003;37: 113–22. doi: 10.1002/gene.1023314595834
52. Karch CM, Cruchaga C, Goate AM, Alzheimer’s disease genetics: from the bench to the clinic. Neuron. 2014;83: 11–26. doi: 10.1016/j.neuron.2014.05.04124991952
53. Shulman JM, Drosophila and experimental neurology in the post-genomic era. Exp Neurol. 2015; doi: 10.1016/j.expneurol.2015.03.01625814441
54. Bellen HJ, Yamamoto S, Morgan’s legacy: fruit flies and the functional annotation of conserved genes. Cell. 2015;In press. https://www.ncbi.nlm.nih.gov/pubmed/26406362
55. Liu X, Jian X, Boerwinkle E, dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013;34: E2393–402. doi: 10.1002/humu.2237623843252
56. Snow PM, Patel NH, Harrelson AL, Goodman CS, Neural-specific carbohydrate moiety shared by many surface glycoproteins in Drosophila and grasshopper embryos. J Neurosci. 1987;7: 4137–44. Available: http://www.ncbi.nlm.nih.gov/pubmed/33202833320283
57. Robinow S, White K, Characterization and spatial distribution of the ELAV protein during Drosophila melanogaster development. J Neurobiol. 1991;22: 443–61. doi: 10.1002/neu.4802205031716300
58. Li B, Dewey CN, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. BioMed Central; 2011;12: 323. doi: 10.1186/1471-2105-12-32321816040
59. Bray NL, Pimentel H, Melsted P, Pachter L, Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2016;34: 525–527. doi: 10.1038/nbt.351927043002